CannaPharmaRx, Inc. Contemplates Genetic Division

  • a future leader in ultramodern, highly efficient facilities in Canada for the distribution to wholesale licensed cannabis retailers, announced today that the Company has been looking to expand their brand with a new genetics division.
  • ” Different cannabis users are looking for different results within the various strains of cannabis they are utilizing,” said Nick Colvin, CEO of CannaPharmaRx.
  • CannaPharmaRx is focused on the acquisition and development of state-of-the-art cannabis grow facilities located in Canada.
  • CPMD has recently completed an initial acquisition of a 48,500 square foot cannabis grow facility presently under development and is currently in discussion with other companies regarding potential acquisitions or business combinations.

Read full article: